An Elvitegravir Nanoformulation Crosses the Blood–Brain Barrier and Suppresses HIV-1 Replication in Microglia

Yuqing Gong(University of Tennessee Health Science Center), Santosh Kumar(University of Tennessee Health Science Center)
Viruses
May 20, 2020
Cited by 33


Related Papers